CollPlant Biotechnologies Ltd.
CLGN
$2.35
-$0.07-2.89%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | -7.13% | -7.13% | -175.96% | ||
| Total Depreciation and Amortization | 4.41% | 4.41% | 2.26% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -42.43% | -42.43% | 24.07% | ||
| Change in Net Operating Assets | -83.46% | -83.46% | 199.65% | ||
| Cash from Operations | -134.61% | -134.61% | 280.98% | ||
| Capital Expenditure | 5.76% | 5.76% | 27.89% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | 100.00% | ||
| Cash from Investing | -53.09% | -53.09% | 38.64% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -100.00% | -100.00% | 142.70% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -100.00% | -100.00% | 142.70% | ||
| Foreign Exchange rate Adjustments | 248.51% | 248.51% | 17.28% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -138.07% | -138.07% | 257.01% | ||